Transdermal delivery of ketorolac tromethamine: Effects of vehicles and penetration enhancers

Drug Development and Industrial Pharmacy

Volumn 30, Issue 6, 2004, Pages 557-564

  Cho, Young Ah ^a   Gwak, Hye Sun ^a  

^a Chosun University   (South Korea)

Author keywords

Ketorolac tromethamine; Penetration enhancers; Transdermal delivery; Vehicles

Indexed keywords

DIETHYLENE GLYCOL MONOETHYL ETHER; DRUG VEHICLE; KETOROLAC TROMETAMOL; LAURIC ACID; LINOLEIC ACID; OLEIC ACID; PROPYLENE GLYCOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; LIPID COMPOSITION; MALE; MOUSE; NONHUMAN; NUDE MOUSE; SKIN PENETRATION;

ADJUVANTS, PHARMACEUTIC; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ETHYLENE GLYCOLS; KETOROLAC TROMETHAMINE; MALE; MICE; MICE, INBRED HRS; PERMEABILITY; PHARMACEUTICAL SOLUTIONS; PROPYLENE GLYCOLS; SKIN ABSORPTION; SOLUBILITY; SOLVENTS; VEHICLES;

EID: 3142727714     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120037486     Document Type: Article

References (20)

1. Buckley, M.M.; Brogden, R.N.; Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 1990, 39 (1), 86-109.
2. Rooks, W.H.; Maloney, P.J.; Shott, L.D.; Schuler, M.E.; Sevelius, H.; Strosberg, A.M.; Tanenbaum, L.; Tomolonis, A.J.; Wallach, M.B.; Waterbury, D.; Yee, J.P. The analgesic and anti-inflammatory profile of ketorolac and its tromethamine salt. Drugs Exp. Clin. Res. 1985, 11 (8), 479-492.
3. Tiwari, S.B.; Udupa, N. Investigation into the potential of iontophoresis facilitated delivery of ketorolac. Int. J. Pharm. 2003, 260, 93-103.
4. Reinhart, D.I. Minimizing the adverse effects of ketorolac. Drug Safety 2000, 22, 487-497.
5. Roy, S.D.; Manoukian, E.M.; Combs, D. Absorption of transdermally delivered ketorolac acid in humans. J. Pharm. Sci. 1995, 84 (1), 49-52.
6. Roy, S.D.; Manoukian, E. Transdermal delivery of ketorolac tromethamine: permeation enhancement, device design, and pharmacokinetics in healthy humans. J. Pharm. Sci. 1995, 84 (10), 1190-1196.
7. Choi, H.K.; Angello, J.T. Mathmatical analysis and optimization of flowthrough diffusion cell system. Pharm. Res. 1994, 11, 595-599.
8. Barry, B.W. Percutaneous absorption. In Dermatological Formulations; Barry, B.W., Ed.; Marcel Dekker, Inc.: New York, 1983; 49-94.
9. Twist, J.N.; Zata, J.L. The effect of solvents on solute penetration through fuzzy rat skin in vitro. J. Soc. Cosmet. Chem. 1990, 40, 231-242.
10. Barry, B.W. Mode of action of penetration enhancers in human skin. J. Control. Release 1987, 6, 85-97.
11. Green, P.G.; Guy, R.H.; Hadgraft, J. In vitro and in vivo enhancement of skin permeation with oleic acid and lauric acids. Int. J. Pharm. 1988, 48 (1-3), 103-111.
12. Yamada, M.; Uda, Y.; Tanigawara, Y. Mechanism of enhancement of percutaneous absorption of molsidomine by oleic acid. Chem. Pharm. Bull. 1987, 35 (8), 3399-3406.
13. Cho, Y.J.; Choi, H.K. Enhancement of percutaneous absorption of ketoprofen: effect of vehicles and adhesive matrix. Int. J. Pharm. 1998, 169 (1), 95-104.
14. Cooper, E.R. Increased skin permeability for lipophilic molecules. J. Pharm. Sci. 1984, 73 (8), 153-1156.
15. Cooper, E.R.; Merritt, E.W.; Smith, R.L. Effect of fatty acids and alcohols on the penetration of acyclovir across human skin in vitro. J. Pharm. Sci. 1985, 74 (6), 688-689.
16. Aungst, B.J.; Rgers, N.J.; Shefter, E. Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int. J. Pharm. 1986, 33 (1-3), 225-234.
17. Hoelgaard, A.; Møllgaard, B.; Baker, E. Vehicle effect on topical drug delivery. IV. Effect of N-methylpyrrolidone and polar lipids on percutaneous drug transport. Int. J. Pharm. 1988, 43, 233-240.
18. Gwak, H.S.; Chun, I.K. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin. Int. J. Pharm. 2002, 236 (1-2), 57-64.
19. Gwak, H.S.; Oh, I.S.; Chun, I.K. Transdermal delivery of ondansetron hydrochloride: effects of vehicles and penetration enhancers. Drug Dev. Ind. Pharm. 2004, 30 (2), 187-194.
20. Sato, K.; Sgibayashi, K.; Morimoto, Y. Species difference in percutaneous absorption of nicorandil. J. Pharm. Sci. 1991, 80, 104-107.